We are live on ! Find out more
SAM

Securian Asset Management Portfolio holdings

AUM $2.78B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+6.45%
1 Year Est. Return
+32.11%
3 Year Est. Return
+104.03%
5 Year Est. Return
+138.11%
10 Year Est. Return
+399.93%
AUM
$4.53B
AUM Growth
+$170M
Cap. Flow
-$71.6M
Cap. Flow %
-1.58%
Top 10 Hldgs %
19.76%
Holding
1,044
New
23
Increased
82
Reduced
878
Closed
24

Top Buys

Rank Stock Value
1
CUZ icon
Cousins Properties
CUZ
+$12.8M
2
PLD icon
Prologis
PLD
+$12.1M
3
CCI icon
Crown Castle
CCI
+$11.7M
4
OHI icon
Omega Healthcare
OHI
+$11.5M
5
PK icon
Park Hotels & Resorts
PK
+$11.5M

Sector Composition

Rank Sector Weight
1 Real Estate 21.14%
2 Technology 12.46%
3 Financials 9.75%
4 Healthcare 8.81%
5 Consumer Discretionary 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
151
Intuitive Surgical
ISRG
$127B
$6.96M 0.15%
35,328
-1,002
-3% -$188K
INTU icon
152
Intuit
INTU
$86.5B
$6.92M 0.15%
26,406
-823
-3% -$215K
SYK icon
153
Stryker
SYK
$125B
$6.83M 0.15%
32,533
-711
-2% -$148K
SPGI icon
154
S&P Global
SPGI
$121B
$6.79M 0.15%
24,863
-930
-4% -$242K
FISV
155
Fiserv Inc
FISV
$28.8B
$6.71M 0.15%
58,071
-1,518
-3% -$168K
SO icon
156
Southern Company
SO
$109B
$6.64M 0.15%
104,245
-2,689
-3% -$167K
TGT icon
157
Target
TGT
$65.6B
$6.56M 0.14%
51,173
-1,095
-2% -$129K
STAG icon
158
STAG Industrial
STAG
$7.38B
$6.51M 0.14%
206,309
-2,700
-1% -$82.8K
CUBE icon
159
CubeSmart
CUBE
$9.39B
$6.43M 0.14%
204,396
-81,044
-28% -$2.6M
O icon
160
Realty Income
O
$59.6B
$6.41M 0.14%
89,873
-97,823
-52% -$7.29M
ZTS icon
161
Zoetis
ZTS
$32.4B
$6.41M 0.14%
48,425
-972
-2% -$121K
BSX icon
162
Boston Scientific
BSX
$69.5B
$6.35M 0.14%
140,423
-5,166
-4% -$216K
AGN
163
DELISTED
Allergan plc
AGN
$6.26M 0.14%
32,767
-884
-3% -$159K
MS icon
164
Morgan Stanley
MS
$331B
$6.26M 0.14%
122,468
-6,176
-5% -$292K
RTN
165
DELISTED
Raytheon Company
RTN
$6.18M 0.14%
28,138
-686
-2% -$145K
EPD icon
166
Enterprise Products Partners
EPD
$82.3B
$6.15M 0.14%
218,400
+10,200
+5% +$276K
MU icon
167
Micron Technology
MU
$930B
$6.05M 0.13%
112,487
-449
-0.4% -$21.4K
BLK icon
168
Blackrock
BLK
$169B
$6M 0.13%
11,926
-327
-3% -$155K
CL icon
169
Colgate-Palmolive
CL
$73.1B
$5.92M 0.13%
86,041
-2,714
-3% -$185K
IVE icon
170
iShares S&P 500 Value ETF
IVE
$49B
$5.92M 0.13%
45,500
+3,200
+8% +$398K
WY icon
171
Weyerhaeuser
WY
$18B
$5.89M 0.13%
195,121
-11,608
-6% -$337K
HIW icon
172
Highwoods Properties
HIW
$3.65B
$5.72M 0.13%
117,049
-284,992
-71% -$13.2M
AMAT icon
173
Applied Materials
AMAT
$403B
$5.72M 0.13%
93,755
-775
-0.8% -$43.6K
VRTX icon
174
Vertex Pharmaceuticals
VRTX
$121B
$5.71M 0.13%
26,070
-812
-3% -$164K
MRSH
175
Marsh
MRSH
$90.5B
$5.67M 0.13%
50,865
-1,565
-3% -$163K

Similar funds

Securian Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Securian Asset Management held 1,044 positions worth $4.53B, up 3.9% from $4.36B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 4.5%. Securian Asset Management opened 23 new positions and exited 24, leaving the 1,044-position portfolio largely intact.

By sector, the portfolio is most concentrated in Real Estate at 21% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Securian Asset Management's largest Q4 2019 buy was Gaming and Leisure Properties: 170,170 shares worth $7.33M.
  • Securian Asset Management added most to Cousins Properties in Q4 2019, an estimated $12.8M increase.
  • Securian Asset Management's biggest Q4 2019 reduction was Highwoods Properties, cutting an estimated $13.2M.
  • Securian Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $7.26M.
  • Securian Asset Management's ten largest holdings make up 20% of its $4.53B portfolio in Q4 2019.
  • Securian Asset Management opened 23 new positions and closed 24 in Q4 2019.
  • Securian Asset Management's portfolio value rose 3.9% quarter-over-quarter to $4.53B.

Based on Securian Asset Management's 13F filing for Q4 2019, filed 4 Feb 2020.